Recombinant Human SSTR2 Protein，His

Somatostatin receptor 2 (SSTR2) is a member of the somatostatin receptor family, which plays a crucial role in various physiological processes, including hormone regulation and cell signaling. SSTR2 is predominantly expressed in the central nervous system and several peripheral tissues, where it modulates neurotransmitter release and cellular proliferation. Its importance in neuroendocrine tumors, particularly in the context of diagnostic imaging and targeted therapies, has spurred significant interest in the development of SSTR2 recombinant proteins for both basic research and clinical applications. By generating these recombinant proteins, researchers aim to elucidate the structural and functional properties of SSTR2, which can aid in understanding its role in disease mechanisms. Moreover, there is a growing focus on utilizing SSTR2 as a therapeutic target, as its activation can inhibit tumor growth and improve treatment outcomes in patients with somatostatin receptor-expressing tumors. The study of SSTR2 recombinant proteins encompasses various methodologies, including protein expression, purification, and characterization, to develop effective ligands and radiotracers that can enhance the specificity and efficacy of SSTR2-targeted therapies. This research not only contributes to the fundamental understanding of receptor biology but also represents a promising avenue for the advancement of targeted treatment strategies in cancer and other pathologies associated with aberrant somatostatin signaling.